Antimicrobial Resistance Surveillance in Retail Food Specimens

Objective

The National Antimicrobial Resistance Monitoring System (NARMS) is a U.S. public health surveillance system that tracks antibiotic resistance in enteric bacteria from humans, retail meats, and food animals. When antimicrobial drugs are used in food-producing animals, they can enrich for populations of resistant strains that reach humans via the food supply. The chief goal of the NARMS retail food surveillance program is to improve the detection of and surveillance for antimicrobial resistance among enteric bacteria in raw retail food commodities, particularly fresh retail meat. The NARMS program is looking to collaborate with institutions or organizations to enhance and strengthen antibiotic resistance surveillance in retail food specimens. Partnering with the NARMS retail food surveillance program will enable the collection of critical data for FDA policy and regulatory actions including but not limited to pre-approval safety evaluation of new animal antibiotics, determining parameters for the antimicrobial use in veterinary medicine, and the ability to provide information to promote interventions to reduce resistance among foodborne bacteria. This collaboration will address NARMS programmatic needs to implement effective surveillance and response for antibiotic resistance as recommended in the National Strategy for Combating Antibiotic-Resistant Bacteria (CARB).

Who Can Apply

• Government - General
• Federal
• Interstate
• Intrastate
• State (includes District of Columbia, public institutions of higher education and hospitals)
• Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals
• Public nonprofit institution/organization (includes institutions of higher education and hospitals)
• Other public institution/organization
• Federally Recognized lndian Tribal Governments
• U.S. Territories and possessions
• U.S. Territories and possessions (includes institutions of higher education and hospitals)
• Minority group
• Small business (less than 500 employees)
• Profit organization
• Private nonprofit institution/organization (includes institutions of higher education and hospitals)
• Other private institutions/organizations
• State
• Native American Organizations (includes lndian groups, cooperatives, corporations, partnerships, associations)

Applicants should review the individual funding opportunity announcement issued under this CFDA program to see which applicant organizations are eligible to apply.

Who Benefits

• Federal
• U.S. Territories
• Minority group
• Specialized group (e.g. health professionals, students, veterans)
• Small business
• Profit organization
• Private nonprofit institution/organization
• Quasi-public nonprofit organization
• Other private institution/organization
• Interstate
• Native American Organizations
• Health Professional
• Education Professional
• Student/Trainee
• Graduate Student
• Scientist/Researchers
• Intrastate
• Small Business Person
• Black
• American Indian
• Spanish Origin
• Asian
• Other Non-White
• State
• Migrant
• Local
• Sponsored organization
• Public nonprofit institution/organization
• Other public institution/organization
• Federally Recognized Indian Tribal Governments

Improving antimicrobial resistance surveillance, food safety, and antimicrobial drug approvals for animals and humans.

Assistance Types

• Cooperative Agreements (Discretionary Grants)

Program Contact

patrick.mcdermott@fda.hhs.gov
240-402-0891